IP Library Granted Patent US 7,655,435
Granted Patent B2
US 7,655,435 · App. 12/079,834 · Granted Feb 2, 2010

Emulsion compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,435
App. No.
12/079,834
Granted
Feb 2, 2010
Kind
B2
Abstract

An emulsion is useful in allowing a wide variety of gene products to be expressed via eukaryotic in vitro expression. The emulsion comprises a silicone based surfactant, a hydrophobic phase and a hydrophilic phase; wherein the hydrophilic phase comprises a plurality of compartments containing a functional in vitro eukaryotic expression system.

Claims (12)

1. A method of obtaining a gene product comprising:

(i) forming an emulsion comprising a surfactant, a hydrophobic phase and a hydrophilic phase, the hydrophilic phase comprising a plurality of microcapsules containing a functional in vitro eukaryotic expression system, wherein the surfactant is a chemically inert silicone-based surfactant;

(ii) allowing the gene product to be expressed by the expression system; and, optionally,

(iii) purifying the gene product.

2. The method of claim 1 , wherein the silicone-based surfactant is a silicone copolymer.

3. The method of claim 2 , wherein, the silicone-based surfactant is polysiloxane-polycetyl-polyethylene glycol copolymer.

4. The method of claim 1 , wherein the surfactant is provided at a v/v concentration in the oil phase of 4%.

5. The method of claim 1 , wherein the eukaryotic expression system comprises a mammalian cell lysate.

6. The method of claim 5 , wherein the lysate is a reticulocyte lysate.

7. The method of claim 5 , wherein the lysate is a rabbit reticulocyte lysate.

8. The method of claim 1 , wherein the emulsion is stable during incubation at 30° C. for at least one hour.

9. The method of claim 1 , wherein the hydrophobic phase comprises a mineral oil.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: MEDICAL RESEARCH COUNCIL
To: UNITED KINGDOM RESEARCH AND INNOVATION
Reel/Frame 046469/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2010
From: HOLLIGER, PHILLIP; GHADESSY, FARID
To: MRC
Reel/Frame 023752/0871 →